0
Upcoming Allied Market Research
2023
Pharmaceutical Analytical Testing Outsourcing Market

Pharmaceutical Analytical Testing Outsourcing Market: Global Opportunity Analysis and Industry Forecast, 2023-2030 Market

Report Code: A10913
Nov 2023 | Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Pharmaceutical Analytical Testing Outsourcing Market

Request Now !

Pharmaceutical Analytical Testing Outsourcing Market Outlook - 2027

The development of the pharmaceuticals brought a revolution in human health. These pharmaceuticals would serve their intent only if they are free from impurities and are administered in an appropriate amount. To make drugs serve their purpose various chemical and instrumental methods were developed at regular intervals which are involved in the estimation of drugs. These pharmaceuticals may develop impurities at various stages of their development, transportation and storage which makes the pharmaceutical risky to be administered thus they must be detected and quantitated. For this analytical instrumentation and methods play an important role. Analytical testing helps in providing real-time product quality control along with optimizing and monitoring processes, characterizing biosimilars and biologics, and improving productivity. One of the main reasons for outsourcing analytical testing services is to benefit from skilled and experienced professionals, as well as to access expensive analytical equipment which are not available in-house. Increased development of biologics is also creating a demand for analytical testing services.

Covid-19 Scenario analysis:

"Solidarity” is an international clinical trial to help find an effective treatment for COVID-19, launched by the World Health Organization and partners. The Solidarity Trial will compare four treatment options against standard of care, to assess their relative effectiveness against COVID-19. By enrolling patients in multiple countries, the Solidarity Trial aims to rapidly discover whether any of the drugs slow disease progression or improve survival. Other drugs can be added based on emerging evidence. Until there is sufficient evidence, WHO cautions against physicians and medical associations recommending or administering these unproven treatments to patients with COVID-19 or people self-medicating with them. WHO is concerned by reports of individuals self-medicating with chloroquine and causing themselves serious harm. Thus, the need of pharmaceuticals and drug testing for COVID-19 drugs is going on full-fledged and thus the market of Pharmaceutical analytical testing outsourcing is expected to witness growth.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact analysis:

Drivers:

Complication of Pharmaceutical analytical testing outsourcing creates need of outsourcing:

The contribution of chemistry, pharmacology, microbiology and biochemistry has set a standard in the drug discovery where new drugs are no longer generated only by the imagination of chemists but these new drugs are the outcome of exchange of ideas between biologists and chemists. The process of drug development starts with the innovation of a drug molecule that has showed therapeutic value to battle, control, check or cure diseases. The synthesis and characterization of such molecules which are also called active pharmaceutical ingredients (APIs) and their analysis to create preliminary safety and therapeutic efficacy data are prerequisites to identification of drug candidates for further detailed investigations. The “compound” which is set to become the drug molecule undergoes safety tests and a series of experiments to prove that it is absorbed in the blood stream, distributed to proper site of action in the body, metabolized sufficiently and demonstrates its non-toxicity thus, can be considered safe and successful. Once the compound is finalized the preclinical research i.e. in vitro studies followed by the animal testing to check kinetics, toxicity and carcinogenicity tests are performed. After passing the pre-clinical tests the regulatory authorities grant permission for the clinical trials. The clinical trials check whether the drug is working in the proposed mechanism or not, its optimum dose and schedule while the last two stages generate statistically important data about efficacy, safety and overall benefit–risk association of the drug. In this phase the potential interaction of the drug with other medicines is determined and monitors drug’s long term effectiveness. After a successful completion of the clinical trials, the drugs are launched in the market for patients thus the need for such intricate testing is required to be outsourced and so the need of outsourcing such services during drug development is required by drug manufactures and so the market of Pharmaceutical analytical testing outsourcing is constantly prerequisite of in the drugs manufacturing industry.

Cost efficiency:

The global pharmaceutical analytical testing services market is expected to grow owing to the rising demand from pharmaceutical manufacturers and raw material suppliers which delivering comprehensive pharmaceutical services in manufacturing and development have become the key concern of several companies. Numerous service providers are offering services such as pharm solutions, packaging, residual solvents, stability testing and storage, method validation, dissolution, raw material testing, leachable or extractable testing, and retrospective method validation. A major trend observed in the global pharmaceutical analytical testing services market is outsourcing. Absence of the necessary set-up for performing every test in-house is one of the key reasons for outsourcing. The best method for handling tests such as process and facility validation, registration stability storage and testing, analytical testing that deploys expensive equipment, cleaning validations, and method development is outsourcing. Outsourcing to a specialty company provides experience and expertise in this domain. It also aids in bringing down the costs of maintenance, equipment, and validation. As a result, outsourcing is likely to contribute towards the expansion of the global pharmaceutical analytical testing market.

Restraints:

The lack of skilled professionals and well-established healthcare infrastructure are some of the factors that threaten to hamper the growth of the pharmaceutical analytical testing services market.

Also, the operational costs, fluctuations in good manufacturing practices (GMP), regulatory policies, and less turnaround times also negatively impact the Pharmaceutical analytical testing outsourcing market growth.

Key benefits of the report:

  • This study presents the analytical depiction of the global Pharmaceutical analytical testing outsourcing industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global Pharmaceutical analytical testing outsourcing market share.
  • The current market is quantitatively analyzed to highlight the global Pharmaceutical analytical testing outsourcing market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global Pharmaceutical analytical testing outsourcing market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Pharmaceutical analytical testing outsourcing Market research report:

  • What are the leading market players active in the Pharmaceutical analytical testing outsourcing market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

Pharmaceutical Analytical Testing Outsourcing Market: Global Opportunity Analysis and Industry Forecast, 2020-2027 Report Highlights

Aspects Details
By Type
  • Active Pharmaceutical Ingredient (API)
  • Additives
  • Finished Products
By Application
  • Bio analytical Testing Method
  • Development and Validation
  • Stability Testing
  • Others
By End User
  • Biopharmaceuticals
  • Pharmaceuticals
  • Contract Manufacturing organizations
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players Pharmaceutical Product Development, LLC, Eurofins Scientific, Toxikon, Inc, Boston Analytical, WuXi AppTec, Inc, Pace Analytical Services, LLC, SGS SA, West Pharmaceutical Services, Inc., Intertek Group PLC
Other Players Charles River Laboratories International, Inc., Merck KGaA., Cambrex Corporation, Catalent, Inc.
 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Active Pharmaceutical Ingredient (API)

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Additives

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Finished Products

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Bio Analytical Testing Method

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Development And Validation

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Stability Testing

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Others

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Biopharmaceuticals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Pharmaceuticals

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Contract Manufacturing Organizations

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Others

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

  • CHAPTER 7: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Type

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Pharmaceutical Analytical Testing Outsourcing Market

        • 7.2.6.1. Market Size and Forecast, By Type
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By End User
      • 7.2.7. Canada Pharmaceutical Analytical Testing Outsourcing Market

        • 7.2.7.1. Market Size and Forecast, By Type
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By End User
      • 7.2.8. Mexico Pharmaceutical Analytical Testing Outsourcing Market

        • 7.2.8.1. Market Size and Forecast, By Type
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By End User
    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Type

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Pharmaceutical Analytical Testing Outsourcing Market

        • 7.3.6.1. Market Size and Forecast, By Type
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By End User
      • 7.3.7. Germany Pharmaceutical Analytical Testing Outsourcing Market

        • 7.3.7.1. Market Size and Forecast, By Type
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By End User
      • 7.3.8. Italy Pharmaceutical Analytical Testing Outsourcing Market

        • 7.3.8.1. Market Size and Forecast, By Type
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By End User
      • 7.3.9. Spain Pharmaceutical Analytical Testing Outsourcing Market

        • 7.3.9.1. Market Size and Forecast, By Type
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By End User
      • 7.3.10. UK Pharmaceutical Analytical Testing Outsourcing Market

        • 7.3.10.1. Market Size and Forecast, By Type
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By End User
      • 7.3.11. Russia Pharmaceutical Analytical Testing Outsourcing Market

        • 7.3.11.1. Market Size and Forecast, By Type
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By End User
      • 7.3.12. Rest Of Europe Pharmaceutical Analytical Testing Outsourcing Market

        • 7.3.12.1. Market Size and Forecast, By Type
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By End User
    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Type

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Pharmaceutical Analytical Testing Outsourcing Market

        • 7.4.6.1. Market Size and Forecast, By Type
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By End User
      • 7.4.7. Japan Pharmaceutical Analytical Testing Outsourcing Market

        • 7.4.7.1. Market Size and Forecast, By Type
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By End User
      • 7.4.8. India Pharmaceutical Analytical Testing Outsourcing Market

        • 7.4.8.1. Market Size and Forecast, By Type
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By End User
      • 7.4.9. South Korea Pharmaceutical Analytical Testing Outsourcing Market

        • 7.4.9.1. Market Size and Forecast, By Type
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By End User
      • 7.4.10. Australia Pharmaceutical Analytical Testing Outsourcing Market

        • 7.4.10.1. Market Size and Forecast, By Type
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By End User
      • 7.4.11. Thailand Pharmaceutical Analytical Testing Outsourcing Market

        • 7.4.11.1. Market Size and Forecast, By Type
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By End User
      • 7.4.12. Malaysia Pharmaceutical Analytical Testing Outsourcing Market

        • 7.4.12.1. Market Size and Forecast, By Type
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By End User
      • 7.4.13. Indonesia Pharmaceutical Analytical Testing Outsourcing Market

        • 7.4.13.1. Market Size and Forecast, By Type
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By End User
      • 7.4.14. Rest of Asia Pacific Pharmaceutical Analytical Testing Outsourcing Market

        • 7.4.14.1. Market Size and Forecast, By Type
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By End User
    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Type

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Pharmaceutical Analytical Testing Outsourcing Market

        • 7.5.6.1. Market Size and Forecast, By Type
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By End User
      • 7.5.7. South Africa Pharmaceutical Analytical Testing Outsourcing Market

        • 7.5.7.1. Market Size and Forecast, By Type
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By End User
      • 7.5.8. Saudi Arabia Pharmaceutical Analytical Testing Outsourcing Market

        • 7.5.8.1. Market Size and Forecast, By Type
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By End User
      • 7.5.9. UAE Pharmaceutical Analytical Testing Outsourcing Market

        • 7.5.9.1. Market Size and Forecast, By Type
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By End User
      • 7.5.10. Argentina Pharmaceutical Analytical Testing Outsourcing Market

        • 7.5.10.1. Market Size and Forecast, By Type
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By End User
      • 7.5.11. Rest of LAMEA Pharmaceutical Analytical Testing Outsourcing Market

        • 7.5.11.1. Market Size and Forecast, By Type
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By End User
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Toxikon, Inc

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Intertek Group PLC

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. SGS SA

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Eurofins Scientific

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Boston Analytical

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Pace Analytical Services, LLC

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. West Pharmaceutical Services, Inc.

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. WuXi AppTec, Inc

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Pharmaceutical Product Development, LLC

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET FOR ACTIVE PHARMACEUTICAL INGREDIENT (API), BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET FOR ADDITIVES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET FOR FINISHED PRODUCTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET FOR BIO ANALYTICAL TESTING METHOD, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET FOR DEVELOPMENT AND VALIDATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET FOR STABILITY TESTING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET FOR BIOPHARMACEUTICALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET FOR PHARMACEUTICALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 20. U.S. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 21. U.S. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 22. U.S. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 23. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 24. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 25. CANADA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 26. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 27. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 28. MEXICO PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 34. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. FRANCE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 37. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 38. GERMANY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 39. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 40. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 41. ITALY PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 43. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 44. SPAIN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 45. UK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 46. UK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 47. UK PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 49. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 50. RUSSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. REST OF EUROPE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 52. REST OF EUROPE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 53. REST OF EUROPE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 54. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 55. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 56. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 57. ASIA-PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 58. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 59. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 60. CHINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 62. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 63. JAPAN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 64. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 65. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 66. INDIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 68. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH KOREA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 70. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 71. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 72. AUSTRALIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 73. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 74. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 75. THAILAND PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 76. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 77. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 78. MALAYSIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 79. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 80. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 81. INDONESIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 82. REST OF ASIA PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 85. LAMEA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 86. LAMEA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 87. LAMEA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 88. LAMEA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 89. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 90. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 91. BRAZIL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 92. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 93. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 94. SOUTH AFRICA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 95. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 96. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 97. SAUDI ARABIA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 98. UAE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 99. UAE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 100. UAE PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 101. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 102. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 103. ARGENTINA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 104. REST OF LAMEA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 105. REST OF LAMEA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 106. REST OF LAMEA PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING, BY END USER, 2022-2032 ($MILLION)
  • TABLE 107. TOXIKON, INC: KEY EXECUTIVES
  • TABLE 108. TOXIKON, INC: COMPANY SNAPSHOT
  • TABLE 109. TOXIKON, INC: OPERATING SEGMENTS
  • TABLE 110. TOXIKON, INC: PRODUCT PORTFOLIO
  • TABLE 111. TOXIKON, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. INTERTEK GROUP PLC: KEY EXECUTIVES
  • TABLE 113. INTERTEK GROUP PLC: COMPANY SNAPSHOT
  • TABLE 114. INTERTEK GROUP PLC: OPERATING SEGMENTS
  • TABLE 115. INTERTEK GROUP PLC: PRODUCT PORTFOLIO
  • TABLE 116. INTERTEK GROUP PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. SGS SA: KEY EXECUTIVES
  • TABLE 118. SGS SA: COMPANY SNAPSHOT
  • TABLE 119. SGS SA: OPERATING SEGMENTS
  • TABLE 120. SGS SA: PRODUCT PORTFOLIO
  • TABLE 121. SGS SA: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 122. EUROFINS SCIENTIFIC: KEY EXECUTIVES
  • TABLE 123. EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
  • TABLE 124. EUROFINS SCIENTIFIC: OPERATING SEGMENTS
  • TABLE 125. EUROFINS SCIENTIFIC: PRODUCT PORTFOLIO
  • TABLE 126. EUROFINS SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 127. BOSTON ANALYTICAL: KEY EXECUTIVES
  • TABLE 128. BOSTON ANALYTICAL: COMPANY SNAPSHOT
  • TABLE 129. BOSTON ANALYTICAL: OPERATING SEGMENTS
  • TABLE 130. BOSTON ANALYTICAL: PRODUCT PORTFOLIO
  • TABLE 131. BOSTON ANALYTICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 132. PACE ANALYTICAL SERVICES, LLC: KEY EXECUTIVES
  • TABLE 133. PACE ANALYTICAL SERVICES, LLC: COMPANY SNAPSHOT
  • TABLE 134. PACE ANALYTICAL SERVICES, LLC: OPERATING SEGMENTS
  • TABLE 135. PACE ANALYTICAL SERVICES, LLC: PRODUCT PORTFOLIO
  • TABLE 136. PACE ANALYTICAL SERVICES, LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 137. WEST PHARMACEUTICAL SERVICES, INC.: KEY EXECUTIVES
  • TABLE 138. WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT
  • TABLE 139. WEST PHARMACEUTICAL SERVICES, INC.: OPERATING SEGMENTS
  • TABLE 140. WEST PHARMACEUTICAL SERVICES, INC.: PRODUCT PORTFOLIO
  • TABLE 141. WEST PHARMACEUTICAL SERVICES, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. WUXI APPTEC, INC: KEY EXECUTIVES
  • TABLE 143. WUXI APPTEC, INC: COMPANY SNAPSHOT
  • TABLE 144. WUXI APPTEC, INC: OPERATING SEGMENTS
  • TABLE 145. WUXI APPTEC, INC: PRODUCT PORTFOLIO
  • TABLE 146. WUXI APPTEC, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC: KEY EXECUTIVES
  • TABLE 148. PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC: COMPANY SNAPSHOT
  • TABLE 149. PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC: OPERATING SEGMENTS
  • TABLE 150. PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC: PRODUCT PORTFOLIO
  • TABLE 151. PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SEGMENTATION
  • FIGURE 2. GLOBAL PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET
  • FIGURE 3. SEGMENTATION PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALPHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET
  • FIGURE 11. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET FOR ACTIVE PHARMACEUTICAL INGREDIENT (API), BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET FOR ADDITIVES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET FOR FINISHED PRODUCTS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 16. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET FOR BIO ANALYTICAL TESTING METHOD, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET FOR DEVELOPMENT AND VALIDATION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET FOR STABILITY TESTING, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET SEGMENTATION, BY BY END USER
  • FIGURE 21. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET FOR BIOPHARMACEUTICALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET FOR CONTRACT MANUFACTURING ORGANIZATIONS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 26. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 27. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 28. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 29. COMPETITIVE DASHBOARD
  • FIGURE 30. COMPETITIVE HEATMAP: PHARMACEUTICAL ANALYTICAL TESTING OUTSOURCING MARKET
  • FIGURE 31. Top player positioning, 2022
  • FIGURE 32. TOXIKON, INC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 33. TOXIKON, INC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 34. TOXIKON, INC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 35. INTERTEK GROUP PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 36. INTERTEK GROUP PLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 37. INTERTEK GROUP PLC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 38. SGS SA: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 39. SGS SA: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 40. SGS SA: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 41. EUROFINS SCIENTIFIC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 42. EUROFINS SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 43. EUROFINS SCIENTIFIC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 44. BOSTON ANALYTICAL: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 45. BOSTON ANALYTICAL: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 46. BOSTON ANALYTICAL: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 47. PACE ANALYTICAL SERVICES, LLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 48. PACE ANALYTICAL SERVICES, LLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 49. PACE ANALYTICAL SERVICES, LLC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 50. WEST PHARMACEUTICAL SERVICES, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. WEST PHARMACEUTICAL SERVICES, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 52. WEST PHARMACEUTICAL SERVICES, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 53. WUXI APPTEC, INC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. WUXI APPTEC, INC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 55. WUXI APPTEC, INC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 56. PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 57. PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 58. PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Pharmaceutical Analytical Testing Outsourcing Market

Start reading.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,840
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers